MedPath

Somatic mosaicism in skin fragility disorders: mechanisms and therapeutic perspectives

Recruiting
Conditions
Epidermolysis bullosa
Q81
Registration Number
DRKS00004362
Lead Sponsor
Klinik für Dermatologie und Venerologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients with epidermolysis bullosa

Exclusion Criteria

none

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Better understanding of revertant mosaicism
Secondary Outcome Measures
NameTimeMethod
To be able to develop therapy approaches for patients with epidermolysis bullosa based on revertant skin cells
© Copyright 2025. All Rights Reserved by MedPath